Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel De Greef

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cureus|October 20, 2025
Upadacitinib in a Refractory Case of Alpha-1 Antitrypsin Deficiency-Related PanniculitisMajda Chaoui, Axel De Greef, Liliane Marot, et al.
European Journal of Dermatology : EJD|August 28, 2024
Lasthenie de Ferjol syndrome associated with skin picking disorderEvelyne Harkemanne, Axel De Greef, Elie Cogan, et al.
BMJ Case Reports|October 10, 2018
Dermatomyositis with anti-TIF1-γ antibodiesAxel De Greef, Liliane Marot, Halil Yildiz, et al.
BMJ Case Reports|January 27, 2025
Bullous pyoderma gangrenosum revealing acute myeloid leukaemiaNoellie Ducastel, Claire Dachelet, Marie Baeck, et al.
Cureus|October 8, 2024
Successful Treatment of Hyaluronic Acid-Induced Facial Necrosis With Intravenous DinoprostoneOlivia Gaudissart, Axel De Greef, Hugues Fierens, et al.
Frontiers in Medicine|November 29, 2023
Atopic dermatitis: a need to define the disease activityAxel De Greef, Laurence de Montjoye, Thomas Bieber, et al.
Dermatology and Therapy|September 17, 2023
Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up DataAxel De Greef, Romane Thirion, Pierre-Dominique Ghislain, et al.
Advances in Therapy|March 22, 2023
Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and AdultsAxel De Greef, Pierre-Dominique Ghislain, Laurence de Montjoye, et al.
JAMA Dermatology|July 31, 2024
Upadacitinib for Treatment of Granulomatous CheilitisAxel De Greef, Caroline Peeters, Olivier Dewit, et al.
Cureus|September 6, 2024
Infantile Bullous Pemphigoid: Vaccination and SARS-CoV-2 Infection as TriggersHéloise Moens, Louise N Delcambre, Axel De Greef, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cureus|October 20, 2025
Upadacitinib in a Refractory Case of Alpha-1 Antitrypsin Deficiency-Related PanniculitisMajda Chaoui, Axel De Greef, Liliane Marot, et al.
European Journal of Dermatology : EJD|August 28, 2024
Lasthenie de Ferjol syndrome associated with skin picking disorderEvelyne Harkemanne, Axel De Greef, Elie Cogan, et al.
BMJ Case Reports|October 10, 2018
Dermatomyositis with anti-TIF1-γ antibodiesAxel De Greef, Liliane Marot, Halil Yildiz, et al.
BMJ Case Reports|January 27, 2025
Bullous pyoderma gangrenosum revealing acute myeloid leukaemiaNoellie Ducastel, Claire Dachelet, Marie Baeck, et al.
Cureus|October 8, 2024
Successful Treatment of Hyaluronic Acid-Induced Facial Necrosis With Intravenous DinoprostoneOlivia Gaudissart, Axel De Greef, Hugues Fierens, et al.
Frontiers in Medicine|November 29, 2023
Atopic dermatitis: a need to define the disease activityAxel De Greef, Laurence de Montjoye, Thomas Bieber, et al.
Dermatology and Therapy|September 17, 2023
Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up DataAxel De Greef, Romane Thirion, Pierre-Dominique Ghislain, et al.
Advances in Therapy|March 22, 2023
Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and AdultsAxel De Greef, Pierre-Dominique Ghislain, Laurence de Montjoye, et al.
JAMA Dermatology|July 31, 2024
Upadacitinib for Treatment of Granulomatous CheilitisAxel De Greef, Caroline Peeters, Olivier Dewit, et al.
Cureus|September 6, 2024
Infantile Bullous Pemphigoid: Vaccination and SARS-CoV-2 Infection as TriggersHéloise Moens, Louise N Delcambre, Axel De Greef, et al.
Pageof 3